Skip to Content
Merck
CN
  • Anaphylactic reaction to different gonadotropin-releasing hormone agonists for the treatment of endometriosis.

Anaphylactic reaction to different gonadotropin-releasing hormone agonists for the treatment of endometriosis.

The American journal of the medical sciences (2011-01-15)
Annemarie B Lüchinger, Velja Mijatovic, Thomas Rustemeyer, Peter G A Hompes
ABSTRACT

Anaphylactic reactions to gonadotropin-releasing hormone (GnRH) agonists are exceedingly rare, but if they occur, they can be life threatening. This case describes a 33-year-old patient with endometriosis who developed an acute allergic reaction on leuprolide (Lucrin) administration. Although skin tests with the replacement goserelin (Zoladex) were negative, usage of this medication resulted in a similar allergic reaction. This is the first case report that shows that, in case of a proven allergy to one GnRH agonist, a switch to another GnRH agonist should not be made even if allergy tests are negative for this medication.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Clemastine fumarate salt, ≥98% (HPLC)